Events

Presentation at SITC Shows Potential to Flag Solid Tumours as a Target for the Immune System to Attack Using the Company’s DCOne® Cell Vaccine Loaded with a Foreign Antigen
Martinsried/ Munich Medigene AG announces that immune monitoring data during the first year of treatment from the ongoing Phase I / II clinical trial with Medigene’s DC vaccine for the treatment of acute myeloid leukemia will be presented at the upcoming ASH Annual Meeting taking place 7 - 10 December 2019 in Orlando, Florida, USA.
Presentations highlight lead product candidate ADCT-402 as a single agent and in combination with checkpoint inhibitor durvalumab for relapsed or refractory B-cell non-Hodgkin lymphomas
Heidelberg Pharma AG announced that they will participate at the following investor events and scientific conferences.
Dr. Ge Li wins ‘CEO of the year’ and John Chiminski a ‘lifetime achievement award’, with a further 11 outstanding winners unveiled
Event provides a perfect partnering platform to exchange with industry executives and to look for novel approaches to fight antimicrobial resistance
walk2Wellness interim study data demonstrate improvement in balance, walking speed and fall reduction
The arrival of patient-centric CDMO’s predicted by CPhI Annual Report
Leveraging the concept of virtual assistants, BASF expertise becomes available to its customers, supporting during all stages of the drug development process
MC Services AG, a leading international public relations and investor relations firm, announced that it will support the 25th annual BIO-Europe® 2019, Europe’s largest partnering conference for the global life sciences industry, as a media partner.
PRESS RELEASES